Yan, Z.-Q. | bioRxiv Science

bioRxiv2025

Chemerin-CMKLR1 mediated OGD/R induced Mitochondrial Dysfunction, Oxidative Stress, and Autophagy differentially in Microglia and Neurons

IntroductionIschemia-reperfusion (I/R) injury exacerbates tissue damage upon reperfusion after ischemia. The impact of chemerin and its receptor, chemokine-like receptor 1 (CMKLR1) on I/R injury remains poorly understood. We hypothesized that chemerin-CMKLR1 differentially regulates signaling in microglia and neuronal cells oxygen-glucose deprivation/reoxygenation (OGD/R), influencing mitochondrial function, oxidative stress, and autophagy. MethodsUsing BV2 microglia and Neuro-2a (N2a) neuronal cells, we examined OGD/R-induced changes in autophagy associated proteins, chemerin and CMKLR1 expression. We investigated the functional consequences of CMKLR1 overexpression and chemerin treatment on oxidative stress, apoptosis, autophagy, and mitochondrial dynamics in BV2 microglia and N2a neuronal cells. ResultsOGD/R downregulated CMKLR1 while upregulating autophagy in both BV2 microglia and N2a cells; While chemerin expression decreased in BV2 microglia but increased in N2a cells following OGD/R. Treatment with chemerin dose-dependently reduced oxidative stress and apoptosis while enhancing mitochondrial fusion, suppressing fission, and promoting autophagy and mitochondrial function in both cell types under OGD/R. CMKLR1 overexpression exacerbated mitochondrial respiratory dysfunction, mitochondrial fusion, fission, and elevated autophagy (LC3II/LC3I and Pink1 levels), with cell-type-specific differences observed in Parkin and P62 regulation. ConclusionOur study demonstrates cell-type-specific regulation of chemerin-CMKLR1 signaling in I/R injury, and distinct mitophagy activation mechanisms in microglia and neurons. These findings suggest cell-type specific modulation of chemerin-CMKLR1 as a potential therapeutic target in preserving mitochondrial homeostasis, modulating autophagy, mitophagy and reducing oxidative stress, apoptosis in both microglia and neurons for mitigating I/R injury.

neuroscience↗

bioRxiv2025

NOD1 ligand FK565 promotes atherogenesis and accumulation of NOD1high smooth muscle cells in atherosclerotic lesions

AimsNucleotide-binding oligomerization domain-containing protein (NOD)1 is an intracellular pattern recognition receptor that initiates immune responses upon ligation of molecules such as bacterial peptidoglycan containing a D-glutamyl-meso-diaminopimelic acid (iE-DAP) moiety. NOD1 ligation has been shown to promote vascular inflammation and atherosclerosis. In this study, we investigate the functional role of NOD1 in atherosclerotic plaques and characterize the vascular cells responsible for NOD1 expression and function. Methods and resultsNOD1 was mainly expressed in a subtype of vascular smooth muscle cells (SMC) in human atherosclerotic lesions. In ex vivo cultures, human endarterectomy specimens reacted to NOD1 ligand by activation of mitogen-activated protein kinase (MAPK) pathways, leading to cytokine expression. Levels of NOD1 mRNA were higher in carotid endarterectomy specimens obtained from symptomatic patients compared to asymptomatic ones. NOD1high SMC were also found in arteries of atherosclerosis-prone Ldlr-/- mice. Challenging these mice with a NOD1 agonist resulted in transmural vascular inflammation, severe arterial damage, accelerated atherogenesis throughout the aorta, and evidence of occlusive coronary artery disease. In rats, mechanic injury to carotid arteries promoted NOD1high SMC expansion and neointima formation. In vitro, neointima derived NOD1high SMCs responded to NOD1 ligand exposure by enhanced migration, increased iNOS+ cells and amplified CCL5 production. ConclusionOur findings show that NOD1 promotes vascular inflammation, vascular injury responses and atherosclerosis by acting on a NOD1high subtype of SMC.

immunology↗